Task: Please answer the following question about the molecule with SMILES CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1.
Request: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Answer: Approved
Task: Please answer the following question about the molecule with {SMILES__description} {SMILES#}.
{#Description|Question|Request!}: {quest#}
{#Result|Answer|Completion!}: {answ#}
CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1
CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1
2-[2-(4-chlorophenyl)-1,3-benzoxazol-5-yl]propanoic acid
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.